Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Lopez-Fauqued, Marta
37  Ergebnisse:
Personensuche X
?
1

Predicting the submission frequency of periodic safety upda..:

Gordillo-Marañón, María ; Candore, Gianmario ; López-Fauqued, Marta...
Frontiers in Medicine.  11 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
2

Understanding thrombosis with thrombocytopenia syndrome aft..:

Buoninfante, Alessandra ; Andeweg, Arno ; Baker, Alexander T....
npj Vaccines.  7 (2022)  1 - p. , 2022
Link: https://doi.org/10.1038/..
 
?
3

Safety Profile of the Adjuvanted Recombinant Zoster Vaccine..:

López-Fauqued, Marta ; Co-van der Mee, Maribel ; Bastidas, Adriana...
Drug Safety.  44 (2021)  7 - p. 811-823 , 2021
Link: https://doi.org/10.1007/..
 
?
4

Review of the initial post-marketing safety surveillance fo..:

Tavares-Da-Silva, Fernanda ; Co, Maribel Miranda ; Dessart, Christophe...
Vaccine.  38 (2020)  18 - p. 3489-3500 , 2020
Link: https://doi.org/10.1016/..
 
?
5

Immunogenicity and Safety of the Adjuvanted Recombinant Zos..:

Vink, Peter ; Ramon Torrell, Josep Maria ; Sanchez Fructuoso, Ana...
Clinical Infectious Diseases.  , 2019
Link: https://doi.org/10.1093/..
 
?
6

Safety profile of the adjuvanted recombinant zoster vaccine..:

López-Fauqued, Marta ; Campora, Laura ; Delannois, Frédérique...
Vaccine.  37 (2019)  18 - p. 2482-2493 , 2019
Link: https://doi.org/10.1016/..
 
?
7

2776. Post-marketing Safety Surveillance for the Adjuvanted..:

Tavares-Da-Silva, Fernanda ; Miranda Co, Maribel ; Dessart, Cristophe...
Open Forum Infectious Diseases.  6 (2019)  Supplement_2 - p. S979-S980 , 2019
Link: https://doi.org/10.1093/..
 
?
8

2483. Twelve-Month Immunogenicity and Safety of an Adjuvant..:

Vink, Peter ; Torrell, Josep Maria Ramon ; Sanchez-Fructuoso, Ana I...
Open Forum Infectious Diseases.  5 (2018)  suppl_1 - p. S744-S745 , 2018
Link: https://doi.org/10.1093/..
 
?
9

149. Immunogenicity, Safety, and Post-hoc Efficacy Assessme..:

Dagnew, Alemnew F ; Ilhan, Osman ; Lee, Won-Sik...
Open Forum Infectious Diseases.  5 (2018)  suppl_1 - p. S9-S10 , 2018
Link: https://doi.org/10.1093/..
 
?
10

A randomized lot-to-lot immunogenicity consistency study of..:

Strezova, Ana ; Godeaux, Olivier ; Aggarwal, Naresh...
Vaccine.  35 (2017)  48 - p. 6700-6706 , 2017
Link: https://doi.org/10.1016/..
 
?
11

Results of a Safety Pooled Analysis of an Adjuvanted Herpes..:

López-Fauqued, Marta ; Campora, Laura ; Delannois, Frédérique...
Open Forum Infectious Diseases.  4 (2017)  suppl_1 - p. S416-S416 , 2017
Link: https://doi.org/10.1093/..
 
?
12

Results on exposure during pregnancy from a pregnancy regis..:

López-Fauqued, Marta ; Zima, Julia ; Angelo, Maria-Genalin.
Vaccine.  35 (2017)  40 - p. 5325-5330 , 2017
Link: https://doi.org/10.1016/..
 
?
13

Understanding thrombosis with thrombocytopenia syndrome aft..:

Buoninfante, Alessandra ; Andeweg, Arno ; Baker, Alexander T...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9643955/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
14

Safety profile of the adjuvanted recombinant zoster vaccine..:

López-Fauqued, Marta ; Campora, Laura ; Delannois, Frédérique...
1873-2518.  , 2020
Link: https://trepo.tuni.fi/ha..
 
?
15

Immunogenicity and Safety of the Adjuvanted Recombinant Zos..:

Vink, Peter ; Ramon Torrell, Josep Maria ; Sanchez Fructuoso, Ana...
http://hdl.handle.net/10668/13670.  , 2020
Link: http://hdl.handle.net/10..
 
1-15